<DOC>
	<DOCNO>NCT02637765</DOCNO>
	<brief_summary>This prospective randomized control trial patient previous breast cancer randomize two treatment arm : 1 . Control Group Usual Physical Activity 2 . Intervention Group Increased Physical Activity No specific intervention perform In patient randomize control group . Patients randomized Intervention group receive program increase physical activity start 5000 steps/day 12000 steps/day 8 week . At time patient group receive 8-week recreational program brisk walking/running ( 3 time week ) . All patient enrol trial receive pedometer device ( Garmin Vìvofit ) able count number step , determine daily goal step , determine cover distance ( Km ) , determine daily caloric consumption , determine movement sleep .</brief_summary>
	<brief_title>Life ImproVed Exercise ( LIVE Trial )</brief_title>
	<detailed_description>In prospective randomize controlled trial patient previous breast cancer randomize two treatment arm : 1 . Control Group Usual Physical Activity 2 . Intervention Group Increased Physical Activity No specific intervention perform In patient randomize control group . Patients randomized Intervention Group receive program increase physical activity start 5000 steps/day 12000 steps/day 8 week . At time patient group receive 8-week recreational program brisk walking/running ( 3 time week ) . All patient enrol trial receive pedometer device ( Garmin Vìvofit ) able count number step , determine daily goal step , determine cover distance ( Km ) , determine daily caloric consumption , determine movement sleep . Data download specific application available online ( Garmin Connect ) . All patient receive write information potential benefit physical exercise well lifestyle . At baseline , end study period ( 8 week ) 1 year patient ask fill follow questionnaire : - Funcional Assessment Cancer Therapy- Breast ( FACT-B , 37 item ) - Patient report symptom ( PRS like International Breast Cancer Study Group form , 19 item ) - Funcional Assessment Cancer Therapy- Fatigue ( FACT-Fatigue , 13 item ) - Functional Assessment Cancer Therapy-Cognitive Function ( FACT-Cog ; 37 item ) - Impact Event Scale ( IES ; 22 item ) At baseline , end study period ( 8 week ) patient ask undergo blood draw serum analysis insulin , IGF-1 , leptin , PCR , cholesterol , triglyceride leucocyte count , T lymphocyte subpopulation ( T regulatory TH17 ) . The hypothesis study even short course increase physical activity may improve quality life non-regular exerciser woman personal history breast cancer complete treatment ( endocrine treatment exclude ) .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Women personal history breast cancer AND Written inform consent AND Willing randomize either group AND Age 1870 year Treatment ( surgery , chemotherapy , radiotherapy , trastuzumab ) complete since least 6 month 3 year ( endocrine therapy allow ) Non regular exerciser ( ≤150 minute per week moderateintense exercise ) . Diabetes insulin metabolic impairment General contraindication regular physical activity participation Inability ambulate Plan relocate far study site Presence severe medical condition patient expect adhere plan study protocol</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Breast Cancer</keyword>
	<keyword>Physical Activity</keyword>
	<keyword>Quality life</keyword>
</DOC>